| Exonerations in the United States 1989 through 2003 SR Gross, K Jacoby, DJ Matheson, N Montgomery J. Crim. l. & CrimiNology 95, 523, 2004 | 1152 | 2004 |
| Phase II trial of bicalutamide in patients with androgen receptor–positive, estrogen receptor–negative metastatic breast cancer A Gucalp, S Tolaney, SJ Isakoff, JN Ingle, MC Liu, LA Carey, K Blackwell, ... Clinical cancer research 19 (19), 5505-5512, 2013 | 825 | 2013 |
| Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial J Garcia-Aguilar, OS Chow, DD Smith, JE Marcet, PA Cataldo, MG Varma, ... The Lancet Oncology 16 (8), 957-966, 2015 | 633 | 2015 |
| Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment GA Poultsides, EL Servais, LB Saltz, S Patil, NE Kemeny, JG Guillem, ... Journal of Clinical Oncology 27 (20), 3379, 2009 | 499 | 2009 |
| HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing … S Modi, A Stopeck, H Linden, D Solit, S Chandarlapaty, N Rosen, ... Clinical Cancer Research 17 (15), 5132, 2011 | 493 | 2011 |
| PIK3CA mutation associates with improved outcome in breast cancer K Kalinsky, LM Jacks, A Heguy, S Patil, M Drobnjak, UK Bhanot, ... Clinical cancer research 15 (16), 5049-5059, 2009 | 437 | 2009 |
| Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy J Garcia-Aguilar, S Patil, MJ Gollub, JK Kim, JB Yuval, HM Thompson, ... Journal of clinical oncology 40 (23), 2546, 2022 | 389 | 2022 |
| A rectal cancer organoid platform to study individual responses to chemoradiation K Ganesh, C Wu, KP O’Rourke, BC Szeglin, Y Zheng, CEG Sauvé, ... Nature medicine 25 (10), 1607-1614, 2019 | 371 | 2019 |
| Clinical management factors contribute to the decision for contralateral prophylactic mastectomy TA King, R Sakr, S Patil, I Gurevich, M Stempel, M Sampson, M Morrow Journal of Clinical Oncology 29 (16), 2158-2164, 2011 | 363 | 2011 |
| Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma DR Feldman, MS Baum, MS Ginsberg, H Hassoun, CD Flombaum, ... Journal of clinical oncology 27 (9), 1432, 2009 | 347 | 2009 |
| Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ U Rudloff, LM Jacks, JI Goldberg, CA Wynveen, E Brogi, S Patil, ... Journal of Clinical Oncology 28 (23), 3762-3769, 2010 | 335 | 2010 |
| Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast AV Barrio, BD Clark, JI Goldberg, LW Hoque, SF Bernik, LW Flynn, ... Annals of surgical oncology 14 (10), 2961-2970, 2007 | 307 | 2007 |
| How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study A Mamtani, AV Barrio, TA King, KJ Van Zee, G Plitas, M Pilewskie, ... Annals of surgical oncology 23, 3467-3474, 2016 | 305 | 2016 |
| Presenting features of breast cancer differ by molecular subtype L Wiechmann, M Sampson, M Stempel, LM Jacks, SM Patil, T King, ... Annals of surgical oncology 16 (10), 2705-2710, 2009 | 270 | 2009 |
| The epichaperome is an integrated chaperome network that facilitates tumour survival A Rodina, T Wang, P Yan, EDG Gomes, MPS Dunphy, N Pillarsetty, ... Nature 538 (7625), 397-401, 2016 | 248 | 2016 |
| TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis DR Feldman, J Sheinfeld, DF Bajorin, P Fischer, S Turkula, N Ishill, S Patil, ... Journal of Clinical Oncology 28 (10), 1706, 2010 | 240 | 2010 |
| Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial. J Garcia-Aguilar, S Patil, JK Kim, JB Yuval, H Thompson, F Verheij, M Lee, ... Journal of Clinical Oncology 38 (15_suppl), 4008-4008, 2020 | 239 | 2020 |
| Causes of death in long‐term survivors of head and neck cancer SS Baxi, LC Pinheiro, SM Patil, DG Pfister, KC Oeffinger, EB Elkin Cancer 120 (10), 1507-1513, 2014 | 233 | 2014 |
| Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer S Chandarlapaty, RA Sakr, D Giri, S Patil, A Heguy, M Morrow, S Modi, ... Clinical Cancer Research 18 (24), 6784-6791, 2012 | 219 | 2012 |
| Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk TA King, M Pilewskie, S Muhsen, S Patil, SK Mautner, A Park, S Oskar, ... Journal of clinical oncology 33 (33), 3945, 2015 | 198 | 2015 |
